1
Epidemiology of cholangiocarcinoma

https://doi.org/10.1016/j.bpg.2015.02.003Get rights and content

Abstract

Cholangiocarcinoma (CCA) is a cancer arising from the intra- or extrahepatic bile ducts and mainly characterized by its late diagnosis and fatal outcome. CCA is the second most common primary liver tumour and accounts for approximately 10–15% of all hepatobiliary malignancies. The development of CCA is linked to a wide spectrum of conditions causing biliary inflammation, cholestasis and inflammation of the liver. The geographic diversity of risk factors is reflected in considerable differences in incidence worldwide. Although data are not consistent, incidence seems to be rising in the Western World. Given the limited opportunities of treating advanced CCA, surveillance has been suggested as a strategy for detection of early disease in the high-risk group of patients with primary sclerosing cholangitis (PSC). In this review we present an updated overview of the epidemiology of CCA. We also highlight the risk of CCA in PSC with special focus on surveillance strategies.

Section snippets

Conflict of interest

None.

Acknowledgements

This work was partially funded by The Swedish Cancer Society, the Bengt Ihre fund and the LMK Foundation.

References (82)

  • S. Tazuma

    Gallstone disease: epidemiology, pathogenesis, and classification of biliary stones (common bile duct and intrahepatic)

    Best Pract Res Clin Gastroenterol

    (2006)
  • Y.H. Shaib et al.

    Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study

    Gastroenterology

    (2005 Mar)
  • T.M. Welzel et al.

    Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study

    Clin Gastroenterol Hepatol

    (2007 Oct)
  • W.C. Palmer et al.

    Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma

    J Hepatol

    (2012 Jul)
  • A. Bergquist et al.

    Hepatic and extrahepatic malignancies in primary sclerosing cholangitis

    J Hepatol

    (2002 Mar)
  • S.E. Kerr et al.

    Biliary dysplasia in primary sclerosing cholangitis harbors cytogenetic abnormalities similar to cholangiocarcinoma

    Hum Pathol

    (2014 Sep)
  • B. Nashan et al.

    Biliary malignancies in primary sclerosing cholangitis: timing for liver transplantation

    Hepatol (Baltimore, Md)

    (1996 May)
  • P. Sangfelt et al.

    Monitoring dominant strictures in primary sclerosing cholangitis with brush cytology and FDG-PET

    J Hepatol

    (2014 Dec)
  • G. Trikudanathan et al.

    Diagnostic yield of bile duct brushings for cholangiocarcinoma in primary sclerosing cholangitis: a systematic review and meta-analysis

    Gastrointest Endosc

    (2014 May)
  • Y.H. Shaib et al.

    Endoscopic and surgical therapy for intrahepatic cholangiocarcinoma in the United States: a population-based study

    J Clin Gastroenterol

    (2007 Nov–Dec)
  • Y. Ustundag et al.

    Cholangiocarcinoma: a compact review of the literature

    World J Gastroenterol

    (2008 Nov 14)
  • S.A. Khan et al.

    Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update

    Gut

    (2012 Dec)
  • International classification of diseases for oncology: ICD-O

    (2000)
  • A. Nakeeb et al.

    Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors

    Ann Surg

    (1996 Oct)
  • M.L. DeOliveira et al.

    Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution

    Ann Surg

    (2007 May)
  • G.L. Tyson et al.

    Risk factors for cholangiocarcinoma

    Hepatol (Baltimore, Md)

    (2011 Jul)
  • S. Sriamporn et al.

    Prevalence of Opisthorchis viverrini infection and incidence of cholangiocarcinoma in Khon Kaen, Northeast Thailand

    Trop Med Int Health

    (2004 May)
  • V. Vatanasapt et al.

    Cancer incidence in Thailand, 1988–1991

    Cancer Epidemiol Biomarkers Prev

    (1995 Jul–Aug)
  • B. Sripa et al.

    Cholangiocarcinoma: lessons from Thailand

    Curr Opin Gastroenterol

    (2008 May)
  • T.M. Welzel et al.

    Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States

    J Natl Cancer Inst

    (2006 Jun 21)
  • S.D. Taylor-Robinson et al.

    Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968–1998

    Gut

    (2001 Jun)
  • T. Patel

    Worldwide trends in mortality from biliary tract malignancies

    BMC Cancer

    (2002 May 3)
  • T. von Hahn et al.

    Epidemiological trends in incidence and mortality of hepatobiliary cancers in Germany

    Scand J Gastroenterol

    (2011 Sep)
  • M. Utada et al.

    Long-term trends in incidence and mortality of intrahepatic and extrahepatic bile duct cancer in Japan

    J Epidemiol

    (2014)
  • P. Jepsen et al.

    Incidence rates of intra- and extrahepatic cholangiocarcinomas in Denmark from 1978 through 2002

    J Natl Cancer Inst

    (2007 Jun 6)
  • G.L. Tyson et al.

    Secular trends in the incidence of cholangiocarcinoma in the USA and the impact of misclassification

    Dig Dis Sci.

    (2014 Dec)
  • N. Kaewpitoon et al.

    Opisthorchiasis in Thailand: review and current status

    World J Gastroenterol

    (2008 Apr 21)
  • P. Sithithaworn et al.

    Roles of liver fluke infection as risk factor for cholangiocarcinoma

    J Hepatobiliary Pancreatic Sci

    (2014 May)
  • H.R. Shin et al.

    Epidemiology of cholangiocarcinoma: an update focusing on risk factors

    Cancer Sci

    (2010 Mar)
  • J.Y. Mabrut et al.

    Management of congenital bile duct cysts

    Dig Surg

    (2010)
  • K. Soreide et al.

    Bile duct cysts in adults

    Br J Surg

    (2004 Dec)
  • Cited by (0)

    View full text